GlaxoSmithKline in Quantum Computing
Drug maker GlaxoSmithKline (GSK) is evaluating Quantum Computing for specific workloads that hit scalability and complexity walls with traditional architectures and approaches, specifically genetic algorithms. Specifically, the company wanted to understand how quantum computing might
